Upwards arrow: Go back to top

Join us on LinkedIn for the latest news.

We use cookies to improve the user experience.
You can read more about our Cookie Policy here.
Accept

Thursday, May 29, 2025

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies